BONNIE ALLEN: Open Payments
NPI 1598131328 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 134 payments from 23 companies in 2025. Trend: 2023 $674 · 2024 $1,018 · 2025 $1,716
Food & beverage: $1,633Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $420 |
| Vanda Pharmaceuticals Inc. | 17 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $175 |
| PFIZER INC. | 9 | $135 |
| CooperSurgical, Inc. | 2 | $102 |
| Lundbeck LLC | 5 | $90 |
| Amgen Inc. | 5 | $84 |
| Novo Nordisk Inc | 4 | $67 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, Paragard T 380A, QULIPTA, NURTEC ODT, UBRELVY.
Industry payments across IN — which companies pay providers there.
